Indo Rama Synthetics approves Rs 200 crore specialty expansion

Indo Rama Synthetics (India) Limited has approved approximately Rs 200 crore for specialty fibre and specialty filament production at Butibori, with commercial operations expected in calendar year 2027 and management estimating about 20% EBITDA growth and a payback of less than two years, subject to execution, ramp-up and market conditions.

What has Indo Rama Synthetics approved for specialty products?

Indo Rama Synthetics has approved approximately Rs 200 crore of additional investment across the company and its wholly owned subsidiary, Indorama Ventures Yarns Private Limited, to produce specialty filament and specialty fibre. Management said the projects will be located within the existing Butibori complex and will complement its current polyester portfolio rather than replace existing production.

The planned spending is a fresh investment, separate from the approximately Rs 628 crore deployed during FY23 and FY24. That earlier programme expanded manufacturing capability and product range, including bottle-grade polyethylene terephthalate, or PET, resin capacity of 2.28 lakh tonnes a year commissioned in June 2023, as well as 39 additional draw textured yarn, or DTY, machines at the subsidiary.

The capital-allocation pattern has changed. Growth capital expenditure moderated to approximately Rs 20 crore in FY25 and around Rs 5 crore in FY26 while Indo Rama Synthetics focused on stabilising the prior expansion; the new Rs 200 crore commitment returns the company to material growth investment after utilisation increased to 68% in FY26 from 58% in FY25.

When will Indo Rama Synthetics' specialty expansion start operations?

Indo Rama Synthetics expects commercial operations from the specialty fibre and specialty filament projects within calendar year 2027. The call did not disclose capacity in tonnes, product-specific realisations, construction milestones or an exact commissioning date, leaving the scale of physical output unspecified.

Management said the Rs 200 crore project will be funded through a combination of term loans and internal accruals. Its current estimate is that the investment could lift top line by around 15% and EBITDA by around 20%, while paying back in less than two years; management expressly qualified each estimate by execution, ramp-up and market conditions.

The project is planned at Butibori, near Nagpur, where Indo Rama Synthetics operates an integrated polyester facility with total capacity of 6.72 lakh tonnes per annum. That includes 2.31 lakh tonnes of polyester staple fibre, 1.70 lakh tonnes of DTY and 2.28 lakh tonnes of bottle-grade PET resin, providing the existing industrial setting for the planned specialty lines.

What operating recovery preceded Indo Rama Synthetics' new investment?

Indo Rama Synthetics' expansion follows a multi-year shift from commissioning and stabilisation towards higher use of installed assets. Capacity utilisation was 58% in FY23, fell to 55% in FY24 amid subdued demand, realisation pressure and higher borrowing costs, recovered to 58% in FY25, and then rose by 10 percentage points to 68% in FY26.

Management attributed the recovery to production efficiency, cost control and the ramp-up of PET resin and textured yarn operations. It said PET resin and value-added textured yarn are contributing alongside established polyester products, although the call did not provide segment revenue, EBITDA or utilisation figures for those individual products.

The FY23 and FY24 transition also coincided with quality-control-order impositions on purified terephthalic acid, or PTA, monoethylene glycol, or MEG, polyester staple fibre and partially oriented yarn, or POY. Management cited geopolitical disruption, competitive imports and subdued demand as factors that affected utilisation during that period.

For H1 FY27, management reported an EBITDA margin of 9.9% and expressed hope that it would be maintained over the next two quarters. Management also said supply-chain conditions that affected volumes in the first two quarters had improved, while crude-related price increases had been passed on to customers.

How does Indo Rama Synthetics' financial position frame the investment?

Indo Rama Synthetics reported improved Q2 FY27 profitability before undertaking the planned specialty project. Total income rose 10% year on year to Rs 1,344 crore, EBITDA increased 46.4% to Rs 117.7 crore, and profit after tax, or PAT, rose 201.8% to Rs 74.1 crore.

Q2 EBITDA margin expanded to 8.8% from 6.6%, while PAT margin increased to 5.5% from 2%. Finance costs declined to Rs 29 crore from Rs 33.6 crore, a Rs 4.6 crore reduction that accompanied the increase in reported quarterly earnings.

H1 FY27 showed a different revenue-profit relationship: total income fell 9.7% to Rs 2,284 crore because mainly of supply-chain issues, but EBITDA rose 24.9% to Rs 225.7 crore and PAT increased 78.3% to Rs 137.8 crore. EBITDA margin increased to 9.9% from 7.1%, while finance costs declined to Rs 58.4 crore from Rs 62.6 crore.

Net cash from operating activities was Rs 328.5 crore in H1 FY27 compared with approximately Rs 92 crore in H1 FY26. Net debt declined 23.5% to approximately Rs 852 crore as of September 30 from Rs 1,113 crore at FY26-end, and debt-to-equity decreased to 1.31 times from 2.18 times before the announced combination of internal accruals and term loans for the specialty project.

Conclusion

Indo Rama Synthetics is committing approximately Rs 200 crore to specialty fibre and filament production after reducing growth spending to around Rs 5 crore in FY26 and increasing capacity utilisation to 68%. Management's projected 15% top-line increase and 20% EBITDA increase are estimates rather than reported outcomes, but they follow H1 FY27 EBITDA growth of 24.9% despite a 9.7% decline in total income.

The next disclosures to watch are execution and commissioning progress towards calendar year 2027, the eventual product capacity and funding mix, and whether net debt remains below the approximately Rs 852 crore reported on September 30. Management also identified supply-chain conditions, crude oil, PTA, MEG, exchange rates and West Asia disruption as matters that could affect costs, availability and ramp-up conditions.